Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 29.52 is 208% above its 5-year average of 9.58, near the high end of its 5-year range (2.86–29.52).
As of the fiscal period ended Tuesday, June 30, 2026. 112.79% above its 12-month average of 13.87.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 29.52.
QUICK RATIO (ACID-TEST)
29.52
QUICK RATIO (ACID-TEST) AVG TTM
13.87
QUICK RATIO (ACID-TEST) AVG 3Y
8.59
QUICK RATIO (ACID-TEST) AVG 5Y
9.58
QUICK RATIO (ACID-TEST) AVG 10Y
6.56
QUICK RATIO (ACID-TEST) AVG 15Y
4.82
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
+112.79%
CURRENT VS 3Y AVG
+243.61%
CURRENT VS 5Y AVG
+208.13%
CURRENT VS 10Y AVG
+350.16%
CURRENT VS 15Y AVG
+512.24%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.30
median of 817 covered companies
CURRENT VS SECTOR MEDIAN
+794.46%
vs the sector median at left
Relmada Therapeutics, Inc.
Market Cap
$348.23M
Quick Ratio (Acid-Test)
29.52
TTM Avg
13.87
3Y Avg
8.59
5Y Avg
9.58
Market Cap
$352.01M
Quick Ratio (Acid-Test)
24.16
TTM Avg
12.00
3Y Avg
8.65
5Y Avg
7.93
Market Cap
$353.60M
Quick Ratio (Acid-Test)
8.24
TTM Avg
5.34
3Y Avg
5.79
5Y Avg
4.44
Market Cap
$354.12M
Quick Ratio (Acid-Test)
3.76
TTM Avg
4.71
3Y Avg
6.65
5Y Avg
8.92
Market Cap
$354.49M
Quick Ratio (Acid-Test)
5.66
TTM Avg
6.21
3Y Avg
5.34
5Y Avg
8.05
Market Cap
$361.31M
Quick Ratio (Acid-Test)
12.19
TTM Avg
4.83
3Y Avg
10.20
5Y Avg
8.85
Market Cap
$363.77M
Quick Ratio (Acid-Test)
1.68
TTM Avg
1.66
3Y Avg
1.70
5Y Avg
1.47
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Relmada Therapeutics, Inc. (RLMD) | $348.23M | 29.52 | 13.87 | 8.59 | 9.58 |
| Artiva Biotherapeutics, Inc. (ARTV)vs › | $352.01M | 24.16 | 12.00 | 8.65 | 7.93 |
| Orchestra BioMed Holdings, Inc. (OBIO)vs › | $353.60M | 8.24 | 5.34 | 5.79 | 4.44 |
| Enanta Pharmaceuticals, Inc. (ENTA)vs › | $354.12M | 3.76 | 4.71 | 6.65 | 8.92 |
| Fennec Pharmaceuticals Inc. (FENC)vs › | $354.49M | 5.66 | 6.21 | 5.34 | 8.05 |
| Ocugen, Inc. (OCGN)vs › | $357.79M | 0.80 | 1.96 | 2.47 | 5.28 |
| Opus Genetics, Inc. (IRD)vs › | $361.31M | 12.19 | 4.83 | 10.20 | 8.85 |
| Embecta Corp. (EMBC)vs › | $363.77M | 1.68 | 1.66 | 1.70 | 1.47 |
| Agenus Inc. (AGEN)vs › | $326.68M | 0.34 | 0.31 | 0.53 | 0.83 |
| CapsoVision, Inc. (CV)vs › | $323.76M | 2.44 | 4.94 | 7.05 | 7.05 |
Quick Ratio
29.52
Excludes inventory
Current Ratio
29.52
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 29.52 |
| 2026-03-31 | 18.26 |
| 2025-12-31 | 14.62 |
| 2025-09-30 | 2.86 |
| 2025-06-30 | 4.11 |
| 2025-03-31 | 5.29 |
| 2024-12-31 | 4.45 |
| 2024-09-30 | 6.89 |
| 2024-06-30 | 7.44 |
| 2024-03-31 | 6.82 |
| 2023-12-31 | 8.00 |
| 2023-09-30 | 12.95 |
| 2023-06-30 | 11.40 |
| 2023-03-31 | 13.42 |
| 2022-12-31 | 12.26 |
| 2022-09-30 | 9.01 |
| 2022-06-30 | 11.40 |
| 2022-03-31 | 14.65 |
| 2021-12-31 | 14.83 |
| 2021-09-30 | 4.98 |
| 2021-06-30 | 7.95 |
| 2021-03-31 | 8.16 |
| 2020-12-31 | 9.37 |
| 2020-09-30 | 37.02 |
| 2020-06-30 | 57.78 |
| 2020-03-31 | 50.97 |
| 2019-12-31 | 80.21 |
| 2019-09-30 | 3.12 |
| 2019-06-30 | 3.65 |
| 2019-03-31 | 1.00 |
| 2018-12-31 | 1.34 |
| 2018-09-30 | 0.13 |
| 2018-06-30 | 0.39 |
| 2018-03-31 | 0.79 |
| 2017-12-31 | 1.31 |
| 2017-09-30 | 1.58 |
| 2017-06-30 | 1.45 |
| 2017-03-31 | 2.64 |
| 2016-12-31 | 3.75 |
| 2016-09-30 | 2.92 |
| 2016-06-30 | 2.86 |
| 2016-03-31 | 4.90 |
| 2015-12-31 | 3.27 |
| 2015-09-30 | 3.02 |
| 2015-06-30 | 1.45 |
| 2015-03-31 | 1.10 |
| 2014-12-31 | 1.17 |
| 2014-09-30 | 0.57 |
| 2014-06-30 | 0.96 |
| 2014-02-28 | 0.06 |
| 2013-11-30 | 0.15 |
| 2013-08-31 | 0.45 |
| 2013-05-31 | 0.03 |
| 2013-02-28 | 0.63 |
| 2012-11-30 | 0.00 |
| 2012-08-31 | 1.71 |
| 2012-05-31 | 0.00 |
| 2012-02-29 | 0.00 |
